Formulation stability studies. 9.1 OBJECTIVE To monitor the stability of the developed herbal formulations using the limited and specific methods.
|
|
- Susanna Chandler
- 6 years ago
- Views:
Transcription
1 9.1 OBJECTIVE To monitor the stability of the developed herbal formulations using the limited and specific methods. 9.2 INTRODUCTION The legal definition of stability is aimed at assuring that the drug / drug product remains within specifications established to ensure its identity, strength, quality and purity. Stability is interpreted as length of time under specific conditions and storage that a product will remain within the pre-defined limits for all its important characteristics (ICH Guidelines; 1993). Stability testing of the herbal formulation is also a important task, for acceptability of the product during its shelf life. Measuring chemical stability is very challenging task due to the complexity of a plant extract, which may contain several hundreds of different compounds. The purpose of stability testing is to provide evidence on how the quality of herbal products varies with the time under the influence of environmental factors. Objective of stability testing: Each ingredient, whether therapeutically active or inactive, in a dosage form can affect stability. Environmental factors such as temperature, light, air (specifically oxygen, carbon dioxide and water vapors) and humidity can affect stability. Drug products are subject to decomposition resulting in loss of potency. The purpose of stability testing is to provide evidences on how the quantity and / or quality of a medicinal substance or drug product varies with time under the influence of a variety of environmental factors such as temperature, humidity and light. Stability testing enables recommended storage conditions, retest periods and shelf lives for the drugs / drug products to be established (ICH Guidelines Q 1 A (R2), 1996) 9.3 LITERATURE REVIEW In-compatibilities between drugs and excipients were quite obvious because of their interactions. Quantization was the most important aspect to determine the presence of substance of interest, it require sensitive methods to determine the same in presence of other components. The same step by step developed from titrimetric to colorimetric reactions, spectrophotometer, TLC, HPLC & GC with different types of detectors are 232
2 even capable to detect small amounts of impurities and decomposition products. (Cartensen, 1994) Regulatory guidelines for stability: The World Health Organization (WHO) has published a guideline Stability testing of pharmaceutical products containing well established drug substances in conventional dosage forms. A new dosage form is defined as a drug product which is a different pharmaceutical product type, but contains the same active substance as included in the existing drug product approved by the pertinent regulatory authority (ICH Harmonized Tripartite Guideline, 1996). ICH defined well in Stability testing of new drug substances and products the choice of test conditions is based on an analysis of the effects of climatic conditions in the three regions of the EC, Japan and the United States. The mean kinetic temperature in any part of the world can be derived from climatic data, and the world can be divided into four climatic zones, I-IV. The principle has been established that stability information generated in any one of the three regions of the EC, Japan and the United States would be mutually acceptable to the other regions, provided the information is consistent with this guideline and the labeling is in accordance with national/regional requirements (ICH Guidelines Q 1 A (R2), 1996). As per the ICH and WHO guidelines, long-term storage condition for zones III and IV, the intermediate storage condition in the general case for zones I and II in the parent guideline is changed to 30 C ± 2 C/65% RH ± 5% RH. This condition of 30 C ± 2 C/65% RH ± 5% RH can also be a suitable alternative to 25 C ± 2 C/60% RH ± 5% RH as the long-term storage condition for Zones I and II. (ICH guidelines Q1 F step-4, 1996). Storage conditions General case For the General case (as described in the parent guideline), the recommended longterm and accelerated storage conditions for Climatic Zones III and IV are shown below table no
3 Table 9.1. Accelerated storage conditions for Climatic Zones III and IV Study Storage condition Long-term 30 C ± 2 C/65% RH ± 5% RH 12 months Accelerated 40 C ± 2 C/75% RH ± 5% RH 6 months Minimum time period covered by data at submission The designated long term testing conditions will be reflected in the labeling and retest date. Long term testing 25 0 C ± 2 0 C / 60% RH ± 5% 12 Months Accelerated Testing 40 0 C ± 2 0 C / 75% RH ± 5% 6 Months No intermediate storage condition for stability studies is recommended for Climatic Zones III and IV. Therefore, the intermediate storage condition is not relevant when the principles of retest period or shelf life extrapolation described in Q1E are applied. (ICH guidelines Q1 F step-4, 1996) Accelerated stability tests In accelerated stability tests, the substance or medicinal product is challenged by a controlled exaggerated stress (storage conditions) over a short time, so that the rate of degradation reaction is enhanced. Therefore, in a relatively short period of time, much information is obtained about the stability of the drug product. Accelerated tests are of particular value in providing information on stability to the formulator in the early stages of product development. The purpose is to determine kinetic parameters to predict the tentative expiry date in a short period of time e. g. 3 6 months. Besides stress testing also helps in validating the stability indicating power of the analytical procedures used. However, accelerated stability is not a substitute for the long-term actual room temperature stability testing. Finally the conditions drawn from accelerated stability testing with respect to extrapolation of shelf life have to be confirmed with the actual ambient room temperature stability testing. The main variables to be considered in a stability testing program are temperature, light and moisture. The effect of light is usually studied in a light cabinet in clear and amber bottles. The effect of moisture is studied by varying the relative humidity and the effect of temperature in constant temperature oven. According to the US-FDA 234
4 guidelines for stability studies, the samples for the accelerated stability data, samples are stored at room temperature and at 40 0 ± 2 0 C; 75 % ± 5 % relative humidity (abbreviated here in after as RH) for a period of six months. 9.4 MATERIALS AND METHODS The prepared formulations were subjected to observation of some parameters like description, identification, weight per ml, ph, viscosity, assay, heavy metals and microbial purity during the stability studies. (Vijay R Salunkhe, 2009) The herbal formulation was used for the stability studies. The changes in the quality of the product may occur due to the interactions between the product and container / closure, which determine the effects of the container on product quality. Based on the present market strategy the herbal formulations are packed in below described manner. 1. Pet bottles with aluminum cap containing rubber cork seal to protect the formulation from external gaseous environment. 2. Glass bottles with aluminum cap containing rubber cork seal to protect the formulation from external gaseous environment. The formulations were packed in the two above-mentioned sets of containers. One set kept in an incubator maintained at storage temperature 25 0 C ± 2 0 C / 60% RH ± 5%. This served as control sample. Another set kept in an oven maintained at accelerated temperature 40 0 C ± 2 0 C / 75% RH ± 5%. The samples were removed from both control and accelerated storage temperature conditions. These samples were analyzed by HPLC using the specified methodology mentioned in HPLC chapter for their photochemical content, at zero days, one, two and three months. At the specified time intervals the sampling was done, the samples in different types of containers were analyzed as per the methodology mentioned in the chromatography section. The results were tabulated for the one active constituent in table no
5 Table 9.2. Specification for Scoparia dulcis Linn. herbal formulation: Code Test Specification T-01 Description Clear Green colored syrup T-02 Identification (By HPLC) T-03 Weight per ml 1.10 to 1.20 gram per ml. T-04 ph 2.50 to 3.50 T-05 Viscosity Between 100 and 210 cps In the Assay test, the retention time of the peaks corresponding to Scopadulcic acid B, Alpha amyrin in the Sample solution matches with the retention time of the peaks corresponding to Scopadulcic acid B, Alpha amyrin obtained with Standard solution T-06 Assay 90.0 % to % of label claim Assay of Scopadulcic Acid B, Sod. Benzoate & Sorbic acid 90.0 % to % of label claim T-07 Heavy Metals (By AAS) Arsenic : Not more than 2 ppm Mercury : Not more than 1 ppm Lead : Not more than 10 ppm Cadmium : Not more than 0.3ppm T-08 Microbiological purity TAMC : NMT 10 5 (Maximum acceptable count: ) CFU/g or CFU/mL TYMC : NMT 10 4 (Maximum acceptable count: ) CFU/g or CFU/mL Bile tolerant gram-negative bacteria : 10 4 CFU/g or CFU/mL Escherichia coli : Absence (1g or ml) Salmonella : Absence (25g or 25mL) 236
6 9.5 RESULTS: Table 9.3. Compiled stability data sheet for Scoparia dulcis Linn. herbal formulation (PET bottle) Test Limits Initial 1 Month 2 Month 3 Month Description Spec* Complies* Complies* Complies* Complies* Complies* Complies* Complies* Identification Spec* Complies* Complies* Complies* Complies* Complies* Complies* Complies* Weight per ml Spec* ph Spec* Viscosity Spec* 130 cps cps Scopadulcic Spec* % % 99.16% % % % 99.98% acid B Alpha amyrin Spec* 99.02% 98.04% 95.10% 96.08% 95.10% 98.04% 95.10% Sod. Benzoate Spec* % % 98.76% Sorbic acid Spec* % % 94.48% Microbial purity Assay TAMC Spec* 65 cfu/ml cfu/ml 84 cfu/ml TYMC Spec* 33 cfu/ml cfu/ml 90 cfu/ml Bile tolerant Spec* Absent Absent Absent gram-negative bacteria. Escherichia coli Spec* Absent Absent Absent Salmonella Spec* Absent Absent Absent Spec*: Refer for specification Complies*: Specification complies, Results obtained are with methods mentioned in chapter 6 and
7 Table 9.4. Compiled stability data sheet for Scoparia dulcis Linn. herbal formulation (Glass bottle) Test Limits Initial 1 Month 2 Month 3 Month Description Spec* Complies* Complies* Complies* Complies* Complies* Complies* Complies* Identification Spec* Complies* Complies* Complies* Complies* Complies* Complies* Complies* Weight per ml Spec* ph Spec* Viscosity Spec* 130 cps cps Scopadulcic Spec* % % 99.29% % % % % acid B Alpha amyrin Spec* 99.02% 99.02% 95.10% 96.08% 95.21% 96.08% 95.10% Sod. Benzoate Spec* % % % Sorbic acid Spec* % % 95.4% Microbial purity Assay TAMC Spec* 65 cfu/ml cfu/ml 94 cfu/ml TYMC Spec* 33 cfu/ml cfu/ml 71 cfu/ml Bile tolerant Spec* Absent Absent Absent gram-negative bacteria. Escherichia coli Spec* Absent Absent Absent Salmonella Spec* Absent Absent Absent Spec*: Refer for specification Complies*: Specification complies, Results obtained are with methods mentioned in chapter 6 and
8 Achyranthes aspera Linn. herbal formulation Table 9.5. Specification for finished product: Code Test Specification 1. Description Clear green colored syrup 2. Identification (BY HPLC) 3. Weight per ml 1.10 to 1.20 gram per ml 4. ph 3.50 to 4.50 In the Assay test, the retention time of the peaks corresponding to Oleanolic acid solution matches with the retention time of the peaks corresponding to Oleanolic acid with Standard solution 5. Viscosity Between 100 and 210 cps 6. Assay 95.0 % to % of label claim Assay of Oleanolic acid Sod. Benzoate & Sorbic acid 7. Heavy Metals (By AAS) 8. Microbiological purity 95.0 % to % of label claim Arsenic : Not more than 2 ppm Mercury : Not more than 1 ppm Lead : Not more than 10 ppm Cadmium : Not more than 0.3ppm TAMC : NMT 10 5 (Maximum acceptable count: ) CFU/g or CFU/mL TYMC : NMT 10 4 (Maximum acceptable count: ) CFU/g or CFU/mL Bile tolerant gram-negative bacteria : 10 4 CFU/g or CFU/mL Escherichia coli : Absence (1g or ml) Salmonella : Absence (25g or 25mL) 239
9 Table 9.6. Compiled stability data sheet for Achyranthes aspera Linn. herbal formulation (PET bottle) Test Limits Initial 1 Month 2 Month 3 Month Description Spec* Complies* Complies* Complies* Complies* Complies* Complies* Complies* Identification Spec* Complies* Complies* Complies* Complies* Complies* Complies* Complies* Weight per ml Spec* ph Spec* Viscosity Spec* 151 cps cps Oleanolic acid Spec* % % 99.39% % 99.39% % % Sod. Benzoate Spec* % 97.82% Sorbic acid Spec* % 94.48% Microbial purity Assay TAMC Spec* 48 cfu/ml cfu/ml 80 cfu/ml TYMC Spec* 36 cfu/ml cfu/ml 86 cfu/ml Bile tolerant Spec* Absent Absent Absent gram-negative bacteria. Escherichia coli Spec* Absent Absent Absent Salmonella Spec* Absent Absent Absent Spec*: Refer for specification Complies*: Specification complies, Results obtained are with methods mentioned in chapter 6 and
10 Table 9.7. Compiled stability data sheet for Achyranthes aspera Linn. herbal formulation (Glass bottle) Test Limits Initial 1 Month 2 Month 3 Month Description Spec* Complies* Complies* Complies* Complies* Complies* Complies* Complies* Identification Spec* Complies* Complies* Complies* Complies* Complies* Complies* Complies* Weight per ml Spec* ph Spec* Viscosity Spec* 151 cps cps Oleanolic acid Spec* % % 98.65% % 98.89% % 98.78% Sod. Benzoate Spec* % 97.33% Sorbic acid Spec* % 95.32% Microbial purity Assay TAMC Spec* 48 cfu/ml cfu/ml 90 cfu/ml TYMC Spec* 36 cfu/ml cfu/ml 60 cfu/ml Bile tolerant Spec* Absent Absent Absent gram-negative bacteria. Escherichia coli Spec* Absent Absent Absent Salmonella Spec* Absent Absent Absent Spec*: Refer for specification Complies*: Specification complies, Results obtained are with methods mentioned in chapter 6 and
11 Poly herbal formulation: Table 9.8. Specification for finished product: Sr. No. Tests Specification 1. Description Dark green colored syrupy liquid with characteristic flavor of pineapple, taste sweet. 2. ph Between 4.0 and Weight per ml Between 1.15 and 1.35 g / ml 4. Viscosity Between 100 and 210 cps 5. Assay of Gallic Acid NLT 65.0 mg per 100 ml 6. Assay of Glycyrrhizic Acid NLT mg per 100 ml 7. Assay of Vasicine NLT 2.0 mg per 100 ml 8. Assay of 6-Gingerol Sod. Benzoate & Sorbic acid 9. Heavy Metals (By AAS) 10. Microbiological purity NLT 2.0 mg per 100 ml 90.0 % to % of label claim Arsenic : Not more than 2 ppm Mercury : Not more than 1 ppm Lead : Not more than 10 ppm Cadmium : Not more than 0.3ppm TAMC : NMT 10 5 (Maximum acceptable count: ) CFU/g or CFU/mL TYMC : NMT 10 4 (Maximum acceptable count: ) CFU/g or CFU/mL Bile tolerant gram-negative bacteria : 10 4 CFU/g or CFU/mL Escherichia coli : Absence (1g or ml) Salmonella : Absence (25g or 25mL) 9.6 DISCUSSION OF RESULTS IN LIGHT OF OTHERS WORK There is no literature reported for the stability study of Achyranthes aspera Linn., Scoparia dulcis Linn. and poly herbal formulations. Description and identification of the formulations complies up to 3 months for samples maintained at.weight per ml, ph, viscosity and microbial purity results remain unchanged and found compliant for all the three herbal formulations. Scopadulcic acid B and Sodium benzoate results comply with specification. Alpha amyrin and Sorbic acid were slightly reduced from initial values in 3 rd month at 40ºC + and found as 95.1% and 94.5 %. Oleanolic acid content was stable and monitored upto 3 month at, Sodium benzoate and Sorbic acid were slightly reduced to 97.8 %and 94.5 %, but found stable at condition. 242
12 Table 9.9. Compiled stability data sheet for poly herbal formulation (PET bottle) Test Limits Initial 1 Month 2 Month 3 Month Description Spec* Complies* Complies* Complies* Complies* Complies* Complies* Complies* Identification Spec* Complies* Complies* Complies* Complies* Complies* Complies* Complies* Weight per ml Spec* ph Spec* Viscosity Spec* 181 cps cps Gallic acid Spec* % % % % 99.53% % 99.37% Glycyrrhizic Spec* % % 98.35% 99.18% 96.75% 97.88% 93.52% acid Vasicine Spec* 99.47% 99.74% % % % % 99.74% 6-Gingerol Spec* % 99.14% 99.43% 99.71% % 98% % Sod. Benzoate Spec* % % % Sorbic acid Spec* % Microbiological purity Assay TAMC Spec* 92 cfu/ml cfu/ml 30 cfu/ml TYMC Spec* 80 cfu/ml cfu/ml 70 cfu/ml Bile tolerant Spec* Absent Absent Absent gram-negative bacteria. Escherichia coli Spec* Absent Absent Absent Salmonella Spec* Absent Absent Absent Spec*: Refer for specification Complies*: Specification complies, Results obtained are with methods mentioned in chapter 6 and
13 Table Compiled stability data sheet for poly herbal formulation (Glass bottle) Test Limits Initial 1 Month 2 Month 3 Month Description Spec* Complies* Complies* Complies* Complies* Complies* Complies* Complies* Identification Spec* Complies* Complies* Complies* Complies* Complies* Complies* Complies* Weight per ml Spec* ph Spec* Viscosity Spec* 181 cps cps Gallic acid Spec* % 101% 100% 101% 98.74% % 99.16% Glycyrrhizic Spec* % 98.69% 97.96% 99.26% 97.95% 97.65% 93.04% acid Vasicine Spec* 99.47% 100.0% % % % % % 6-Gingerol Spec* % Sod. Benzoate Spec* % % 98.13% Sorbic acid Spec* % % 95.08% Microbiological purity Assay TAMC Spec* 92 cfu/ml cfu/ml 35 cfu/ml TYMC Spec* 80 cfu/ml cfu/ml 65 cfu/ml Bile tolerant Spec* Absent Absent Absent gram-negative bacteria. Escherichia coli Spec* Absent Absent Absent Salmonella Spec* Absent Absent Absent Spec*: Refer for specification Complies*: Specification complies, Results obtained are with methods mentioned in chapter 6 and
14 Gallic acid, Vasicine, 6-Gingerol and Sodium benzoate are found stable and are monitored up to 3 month at condition. Glycyrrhizic acid and Sorbic acid were considerably reduced to 93.5 %and 94.3 % but found stable at condition. The packing material has no affect on the stability of the product for all the three formulations, glass and PET bottles results are similar, hence PET bottle is recommended for the product storage and transport. 9.7 CONCLUSION All the above formulations are stable up to 3 months at room temperature and accelerated temperatures of measured contents when packed in PET bottles with Aluminum cap containing rubber cork, Glass bottles with Aluminum cap containing rubber cork inside. 9.8 FUTURE PROSPECTS Studies are required to identify all the chemical components present in the formulation and quantification need to be performed to establish exact shelf life of the product, based on the chemical stability of interested molecules. 9.9 REFERENCES ICH Guidelines: Stability testing of New Drug Substances and Products, 27 th October ICH Harmonized tripartite guideline, Stability testing for new dosage forms ICH harmonized tripartite guideline, Evolution for stability data, current step 4 version dated 6 February Cartensen J.T. Drug Stability Principles and Practices, Marcel Dekker Inc. New York, 2nd edition, Chapter 1994; 1: The tripartite harmonised ICH guideline was finalised (Step 4) in November United States Pharmacopoeia, 24 NF (19), The United States Pharmacopoeia Convention Inc. USA, Vijay R Salunkhe, Journal of Pharmacy Research, 2009; 2:
INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE
INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE STABILITY STUDY FOR ARGEMONE MEXICANA SHIRISH S. PINGALE Department of Chemistry, Gramonnati Mandal s Arts, Com. and Sci. College, Narayangaon,
More informationANNEX III ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES
Association of South East Asian Nations (ASEAN) ANNEX III ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES Disclaimer: This document is provided for information purpose only and subject
More informationASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES (TM) AND HEALTH SUPPLEMENTS (HS)
Association of South East Asian Nations (ASEAN) ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES (TM) AND HEALTH SUPPLEMENTS (HS) Version 3.0 CONTENTS 1. Introduction...2 2. Objective...
More informationMEDICNES CONTROL AGENCY GUIDELINE FOR REGISTRATION OF HERBAL MEDICINAL PRODUCTS IN THE GAMBIA
MEDICNES CONTROL AGENCY GUIDELINE FOR REGISTRATION OF HERBAL MEDICINAL PRODUCTS IN THE GAMBIA Document No.: MCA/HMPG/17/12/01 Date of Adoption: 20 th January 2017 Date of Issue: 25 th July 2017 Version
More informationLegal Requirements for the Control of Contaminants in Herbal Medicinal Products and Related Areas
Legal Requirements for the Control of Contaminants in Herbal Medicinal Products and Related Areas AOAC International Workshop Erlangen, 11 October 2011 Dr. Barbara Steinhoff Contents Heavy metals Microorganisms
More informationICH HARMONISED TRIPARTITE GUIDELINE STABILITY DATA PACKAGE FOR REGISTRATION APPLICATIONS IN CLIMATIC ZONES III AND IV Q1F
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE STABILITY DATA PACKAGE FOR REGISTRATION APPLICATIONS
More informationQUALITY OF HERBAL MEDICINAL PRODUCTS: PRESENT REQUIREMENTS
QUALITY OF HERBAL MEDICINAL PRODUCTS: PRESENT REQUIREMENTS Phytopharm 2015 Bonn, 21 24 July 2015 1 Dr. Barbara Steinhoff Bundesverband der Arzneimittel-Hersteller CONTENTS Production of herbal starting
More informationGood pharmacopoeial practices: Chapter on monographs on herbal medicines
Annex 7 Good pharmacopoeial practices: Chapter on monographs on herbal medicines Background Following the fiftieth meeting of the WHO Expert Committee on Specifications for Pharmaceutical Preparations,
More information6.1 OBJECTIVE To develop simple herbal formulations using the selected plants extract.
6.1 OBJECTIVE To develop simple herbal formulations using the selected plants extract. 6.2 INTRODUCTION many times fails to gain the patient acceptability, hence an attempt was made to increase the same
More informationSTABILITY INDICATING ASSAY. differentiate an intact drug from its potential decomposition products 425.
.1. INTRODUCTION.1.1 STABILITY INDICATING ASSAY The stability - indicating assay is a method that is employed for the analysis of stability samples in pharmaceutical industry. It is essential to validate
More informationSelenoExcell Food & Beverage Product Guide
SelenoExcell Food & Beverage Product Guide is a high potency (1,200 mcg/g), 100% organically bound selenium yeast product. As a natural nutritional food source, yeast replicates the mineral conversion
More informationSCIENTIFIC DISCUSSION
SCIENTIFIC DISCUSSION 1 Introduction This is an application for a CHMP Scientific Opinion in accordance with Article 58 of Regulation (EC) No 726/2004, in the context of cooperation with the World Health
More informationTechnical Monograph n 17, 2nd Edition. Guidelines for Specifying the Shelf Life of Plant Protection Products
Technical Monograph n 17, 2nd Edition Guidelines for Specifying the Shelf Life of Plant Protection Products June 2009 TABLE OF CONTENTS 1. Introduction 3 2. Background 3 3. Definitions 4 4. Outline of
More information3.7 Bracketing. 3.8 Matrixing
chemical characteristics of the dosage form, e.g. magnesium stearate (dissolution), sodium benzoate, (microbiological preservative), etc. 3.6 Liquids Dosage forms intended for oral administration or cutaneous
More information6.02 Uniformity of Dosage Units
6.02 Uniformity of Dosage Units Change 1. Content Uniformity, 3. Criteria and Table 6.02-2 as follows: 1. Content Uniformity Select not less than 30 units, and proceed as follows for the dosage form designated.
More informationAD HOC WORKING GROUP ON HERBAL MEDICINAL PRODUCTS
The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use 28 January 1999 EMEA/HMPWP/16/99 AD HOC WORKING GROUP ON HERBAL MEDICINAL PRODUCTS Final Comments for
More informationJaneen A. Skutnik-Wilkinson ICH Topic co-creator EWG Team Member
Janeen A. Skutnik-Wilkinson ICH Topic co-creator EWG Team Member April 2012 1 Metal Impurities (aka Heavy Metals) STUCK for at least 10 years No Harmonised guidance in ICH or other regions Establish appropriate
More informationStability Study of Hydralazine HCl Oral Solutions Compounded in Humco Oral Vehicles to Determine a Beyond-use Date
Stability Study of Hydralazine HCl Oral Solutions Compounded in Humco Oral Vehicles to Determine a Beyond-use Date Pradeep Gautam, MS* 1, Troy Purvis, PhD 1 Address correspondence to Pradeep Gautam, HUMCO
More informationCELLULOSE, MICROCRYSTALLINE. Cellulosum microcristallinum. Cellulose, microcrystalline EUROPEAN PHARMACOPOEIA 7.0
Cellulose, microcrystalline EUROPEAN PHARMACOPOEIA 7.0 Phthaloyl groups (C 8 H 5 O 3 ; M r 149.1): typically 30.0 per cent to 36.0 per cent (anhydrous and acid-free substance). Dissolve 1.000 g in 50 ml
More informationReceived: ; Revised; Accepted: PROCESS VALIDATION OF FORMOTEROL FUMARATE AND BUDESONIDE DRY POWDER INHALATION
International Journal of Institutional Pharmacy and Life Sciences 2(5): September-October 2012 INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES Pharmaceutical Sciences Original Article!!!
More informationUNICEF Micronutrient Powder Specification
PRODUCT SPECIFICATIONS SHEET Multiple Micronutrient Powder (MNP) 5 Components General Description Multiple Micronutrient Powder 5 component (MNP5), single-use 1 gram sachets, packs of 30 sachets in customised/country
More informationStability of Captopril in an Extemporaneously Compounded Humco s Oral Products
Stability of an Extemporaneously Compounded Humco s Oral Products Pradeep Gautam, MS* 1 1 Address correspondence to Pradeep Gautam, HUMCO Research and Development Laboratory, 201 W. 5 th St. Suite 1250,
More informationTANZANIA BUREAU OF STANDARDS
TBS/AFDC 22 (5279) P3 Dried meat Specification DRAFT TANZANIA STANDARD TANZANIA BUREAU OF STANDARDS Dried meat Specification 0 FOREWORD Dried meat is a meat product obtained through appropriate techniques
More informationINVITATION FOR EXPRESSIONS OF INTEREST (EOI)
INVITATION FOR EXPRESSIONS OF INTEREST (EOI) The Micronutrient Initiative is an international not-for-profit organization based in Canada, dedicated to eliminating vitamin and mineral deficiencies worldwide.
More informationAnalytical method validation. Presented by Debbie Parker 4 July, 2016
Analytical method validation Presented by Debbie Parker 4 July, 2016 Introduction This session will cover: Guidance and references The types of test methods Validation requirements Summary Slide 2 PharmOut
More informationגדות תעשיות ביוכימיה בע"מ Gadot Biochemical Industries Ltd.
Description: Tri Sodium Citrate Anhydrous is a white to off-white free-flowing product. General Characteristics: Formula: C 6 H 5 Na 3 O 7 Molecular weight: 258.08 Appearance: White to off-white granules
More informationPublic Assessment Report Scientific discussion. Ginsana, oral solution. Asp.no.:
Läkemedelsverket 2014-04-15 Public Assessment Report Scientific discussion Ginsana, oral solution (Panax ginseng C.A. Meyer, radix, standardised dry extract G115 Pharmaton (0.9-3.9:1, 40% ethanol)) Asp.no.:
More informationVICH GL58 Stability Testing of New Veterinary Drug Substances and Medicinal Products in Climatic Zones III and IV
1 2 3 19 July 2018 EMA/CVMP/VICH/335918/2016 Committee for Medicinal Products for Veterinary Use (CVMP) 4 5 6 7 VICH GL58 Stability Testing of New Veterinary Drug Substances and Medicinal Products in Climatic
More informationTANZANIA BUREAU OF STANDARDS
TBS/AFDC 14 (5259) P3 Ghee Specification DRAFT TANZANIA STANDARD TANZANIA BUREAU OF STANDARDS Ghee Specification 0 FOREWORD Ghee is a milk product obtained from butter or cream. In Tanzania manufacture
More informationSpecification Sheet : Hemp CBD Isolate
Specification Sheet : Hemp CBD Isolate Description Hemp CBD Isolate is a raw ingredient sold retail as is. It consists of extracted CBD isolate from Colorado. Application and Use Composition Organic Certification
More informationOverview of USP General Chapters <476> and <1086> Prescription/Non-Prescription Stakeholder Forum October 19, 2017
Overview of USP General Chapters and Prescription/Non-Prescription Stakeholder Forum October 19, 2017 Introduction Periodic review of existing general chapters Typically an approximately 5
More informationScientific and Regulatory Basis for Development, Quality Assurance and Marketing Authorisation
Scientific and Regulatory Basis for Development, Quality Assurance and Marketing Authorisation Dr. Frauke Gaedcke, Waidesch Dr. Barbara Steinhoff, Konigswinter In collaboration with Dr. Helga Blasius,
More informationPublic Assessment Report. Scientific discussion. Acetylcysteine YES 600 mg, effervescent tablets. (acetylcysteine) NL/H/2975/001/DC
Public Assessment Report Scientific discussion Acetylcysteine YES 600 mg, effervescent tablets (acetylcysteine) NL/H/2975/001/DC Date: 4 March 2015 This module reflects the scientific discussion for the
More information2. Review of literature: 2.1 General review on methods of simultaneous determination of hypertensive drugs.
2. Review of literature: 2.1 General review on methods of simultaneous determination of hypertensive drugs. Still present many analytical methods are available on traditional or classical methods and these
More informationMicrobiological Quality of Non-sterile Products Culture Media for Compendial Methods
Microbiological Quality of Non-sterile Products Culture Media for Compendial Methods The life science business of Merck operates as MilliporeSigma in the U.S. and Canada. Culture Media for Compendial Methods
More informationINTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CHEMICAL SCIENCES
Research Article Stabilization of Folic Acid in Liquid Dosage Form: Formulation Development, Method Validation and Comparative Analysis Vignesh M 1, Sivakumar M 2, Parkavi V* 1, Selvakumar K 1 and Joysa
More informationPublic Assessment Report. Scientific discussion. Carvedilol Aurobindo 6.25 mg and 25 mg, film-coated tablets (carvedilol) NL/H/2609/ /MR
Public Assessment Report Scientific discussion Carvedilol Aurobindo 6.25 mg and 25 mg, film-coated tablets (carvedilol) NL/H/2609/001-002/MR Date: 26 May 2014 This module reflects the scientific discussion
More informationגדות תעשיות ביוכימיה בע"מ Gadot Biochemical Industries Ltd.
Description: White hygroscopic odorless crystals having a sweet taste. General Characteristics: Formula: C 6 H 12 O 6 Molecular weight: 180 Appearance: White crystals Taste: Sweet Odor: Odorless Solubility
More informationMutual Recognition Procedure. Public Assessment Report. Valproat Orion 300 / 500 mg Retardtabletten. Sodium valproate DE/H/1910/ /MR
Mutual Recognition Procedure Public Assessment Report Valproat Orion 300 / 500 mg Retardtabletten Sodium valproate DE/H/1910/001-002/MR (former FI/H/0608/001-002/MR) Applicant: Orion Corporation Date:
More informationGeneral Chapter/Section: <232> Elemental Impurities - Limits Expert Committee(s): General Chapters Chemical Analysis No.
General Chapter/Section: Elemental Impurities - Limits Expert Committee(s): General Chapters Chemical Analysis No. of Commenters: 18 Editorial changes suggested by commenters have been reviewed by
More informationOLIN CORPORATION SALES SPECIFICATION
PAGE 1 Date Printed: 2015-11-06 Supersedes Date: 09/29/2015 Previous Specified Material: 00008439 Additional Product Information: Clear, Viscous, Hygroscopic Liquid Shelf Life Container Type Conditions
More informationSCIENTIFIC DISCUSSION
This part reflects the scientific knowledge and the information about this product available at the time of prequalification. Thereafter, updates may have become necessary which are included in parts 1
More informationגדות תעשיות ביוכימיה בע"מ Gadot Biochemical Industries Ltd.
Description: Tri Sodium Citrate Dihydrate is a white crystalline product. General Characteristics: Formula: C 6 H 5 Na 3 O. 7 2H 2 O Molecular weight: 294.11 Appearance: White crystals Taste: Saline taste
More informationTechnical Data Sheet. General information. Applications, Dosage and Usage. Ingredient List. Product Break Down. All Technical Data
All Technical Data Technical Data Sheet Revision Date: 7/20/2017 Version: 2 Product Code: 509191020 Product Name: RED IRON OXIDE CAS Number: 1309-37-1 E Number: E172 CI Number: CI 77491 Company Name: Sensient
More informationGOOD PHARMACOPOEIAL PRACTICES Draft chapter on monographs on herbal medicines
7 September 2017 Draft 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 GOOD PHARMACOPOEIAL PRACTICES Draft chapter on monographs on herbal medicines
More informationPublic Assessment Report Scientific discussion
Public Assessment Report Scientific discussion Hypermin, tablet [Hypericum perforatum L., (St. John s wort) herba recens, dry extract (3.1-4.0:1) ethanol 60 %] Asp. no: 2008-1034 This module reflects the
More informationOrganic Impurities in Drug Substances and Drug Products. Antonio Hernandez-Cardoso, M.Sc. Senior Scientific Liaison September 8, 2017
Organic Impurities in Drug Substances and Drug Products Antonio Hernandez-Cardoso, M.Sc. Senior Scientific Liaison September 8, 2017 Potential sources of drug impurities during development AAPS PharmSciTech,
More informationPublic Assessment Report Scientific discussion
Public Assessment Report Scientific discussion Helaflex, film-coated tablet (Harpagophytum procumbens (Burch) DC (devil s claw) dried root, dry extract (4.4-5.0:1) ethanol 60 %) SE/H/1561/01/MR This module
More informationGeneral Concepts in the European Pharmacopoeia. Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe
General Concepts in the European Pharmacopoeia Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe General notices Anne-Sophie Bouin, 28/10/09 2009 EDQM, Council of Europe, All
More informationUNICEF Micronutrient Powder Specification
UNICEF Micronutrient Powder Specification 12.05.2017 PRODUCT SPECIFICATIONS SHEET - - - Multiple Micronutrient Powder (MNP) 15 component General Description: UNICEF stock number: S1580201 UNICEF stock
More informationגדות תעשיות ביוכימיה בע"מ Gadot Biochemical Industries Ltd.
General Characteristics: Formula: Ca 3(C6H5O7(2 *4H2O Molecular weight: 570.6 Appearance: Fine white free flowing powder Odor: Odorless Solubility: In water - Almost insoluble In alcohol - Insoluble CAS
More informationSCIENTIFIC DISCUSSION
SCIENTIFIC DISCUSSION 1 INTRODUCTION This application has been submitted to the EMEA for the CHMP to issue a scientific opinion in accordance with Article 58 of Regulation (EC) No 726/2004, in the context
More informationPublic Assessment Report Scientific discussion
Public Assessment Report Scientific discussion Cynaramin, oral drops, solution (Peumus boldus Molina, folium, liquid extract, (1:10); Taraxacum officinale Web., radix and herba, liquid extract, (1:17))
More informationAbacavir (as sulfate) 300 mg tablets WHOPAR part 6 May 2016 (Hetero Labs Ltd), HA575
This part reflects the scientific knowledge and the information about this product available at the time of prequalification. Thereafter, updates may have become necessary which are included in parts 1
More informationUSP Perspective on Atypical Actives November 29, 2017
USP Perspective on Atypical Actives November 29, 2017 USP Excipients Stakeholder Forum USP Perspective on Atypical Actives Catherine Sheehan, M.S., M.S. Senior Director, Science Excipients Outline Role
More informationLUBRICANT, WATER BASED, NON-IRRITANT, FOR USE DURING INTERCOURSE
LUBRICANT, WATER BASED, NON-IRRITANT, FOR USE DURING INTERCOURSE QUANTITIES REQUIRED: 20 000 000 UNITS PER YEAR (60 000 000 UNITS FOR 3 YEARS) PACKAGING: INDIVIDUALLY PACKED SATCHETS CONTAINING FIVE MILLILITRES
More informationSWEETINDIA Following Synthetic Sweeteners available on regular basis. Acesulfame Potassium Aspartame Sucralose Sodium Cyclamate Sodium Saccharin
SWEETINDIA Following Synthetic Sweeteners available on regular basis. Acesulfame Potassium Aspartame Sucralose Sodium Cyclamate Sodium Saccharin FINISHED PRODUCT INFORMATION Product: Acesulfame Potassium
More informationQUALITY OF HERBAL REMEDIES
QUALITY OF HERBAL REMEDIES Guideline Title Quality of Herbal Remedies Legislative basis Directive 75/318/EEC as amended Date of first adoption November 1988 Date of entry into May 1989 force Status Last
More informationOrnsurang Teerawat
ASEAN TRADITIONAL MEDICINES AND HEALTH SUPPLEMENTS REGULATORY AND HARMONIZATION UPDATE Ornsurang Teerawat 21.10.2014 \ http://trainstudenytp.wordpress.com ACCSQ (ASEAN Consultative Committee for Standard
More informationPublic Assessment Report Scientific discussion
Public Assessment Report Scientific discussion Harpatinum, capsule, soft Harpagophytum procumbens D.C. / H. zeyheri Decne (Devil s claw), radix, dry extract (4.4-5.0:1), ethanol 60 % (V/V) SE/H/1640/01/DC
More informationCollege ter Beoordeling van Geneesmiddelen / Medicines Evaluation Board. Graadt van Roggenweg AH Utrecht The Netherlands
College ter Beoordeling van Geneesmiddelen / Medicines Evaluation Board Graadt van Roggenweg 500 3531 AH Utrecht The Netherlands MUTUAL RECOGNITION PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A
More informationPublic Assessment Report. Scientific discussion. Celecoxib Apotex 100 mg and 200 mg, capsules, hard (celecoxib) NL/H/2760/ /DC
Public Assessment Report Scientific discussion Celecoxib Apotex 100 mg and 200 mg, capsules, hard (celecoxib) NL/H/2760/001-002/DC Date: 29 April 2014 This module reflects the scientific discussion for
More informationPublic Assessment Report. Scientific discussion. Elisox 50 microgram/actuation, nasal spray, suspension. (mometasone furoate) NL/H/2672/001/DC
Public Assessment Report Scientific discussion Elisox 50 microgram/actuation, nasal spray, suspension (mometasone furoate) NL/H/2672/001/DC Date: 24 September 2014 This module reflects the scientific discussion
More informationPublic Assessment Report. Scientific discussion. Rabeprazolnatrium Torrent Pharma. 10 mg and 20 mg gastro-resistant tablets. Rabeprazole sodium
Public Assessment Report Scientific discussion Rabeprazolnatrium Torrent Pharma 10 mg and 20 mg gastro-resistant tablets Rabeprazole sodium DK/H/1819/001-002/DC This module reflects the scientific discussion
More informationUSP Chewable Gels Monographs
USP Dietary Supplements Stakeholder Forum Tuesday, May 15, 2018 USP Chewable Gels Monographs Natalia Davydova, Ph.D. Scientific Liaison DS Gummies Market Value of the gummy vitamins market in the United
More informationPublic Assessment Report for a Traditional Herbal Medicinal Product for Human Use
IPAR Public Assessment Report for a Traditional Herbal Medicinal Product for Human Use Ginkgoforce Memory & Circulation Ginkgo Tablets Extract (as dry extract) from fresh leaves of Ginkgo biloba (Ginkgo
More informationגדות תעשיות ביוכימיה בע"מ Gadot Biochemical Industries Ltd.
Description: GadoMag K is citrate based Magnesium compound, designed to supplement liquid food products conveniently with a readily absorbable form of Magnesium. Best suitable for soy and dairy products
More informationE55A GELATIN, GELLING GRADE Gelatina
00-0PDG.pdf 0 0 0 0 EA GELATIN, GELLING GRADE Gelatina DEFINITION Purified protein obtained from collagen of animals (including fish and poultry) by partial alkaline and/or acid hydrolysis, by enzymatic
More informationDisclosure. Objectives. Objectives. Introduction. Introduction. Non-Sterile Compounding/Calculations
49th Annual Meeting Non-Sterile Compounding/ Sunil Jambhekar, B. Pharm., M.S., Ph.D Professor, Pharmaceutical Sciences LECOM Bradenton, School of Pharmacy Bradenton, FL 34211 Disclosure I do not have a
More informationPublic Assessment Report. Scientific discussion. Pentasa Compact 4 g, prolonged-release granules. (mesalazine) NL License RVG:
Public Assessment Report Scientific discussion Pentasa Compact 4 g, prolonged-release granules (mesalazine) NL License RVG: 114015 Date: 30 March 2015 This module reflects the scientific discussion for
More informationSavesta Herbals is engaged in manufacturing
Savesta Herbals is engaged in manufacturing standardized herbal extracts that synergistically combine the ancient wisdom of Ayurveda with the modern production and QC methods. Our state-of- the- art production
More informationFood supplement manufacture
Food supplement manufacture Nick Bennett BSc. RNutr April 2018 1 Introduction There are many different product formats available Liquids, powders, tablets, capsules etc Many different types of machine
More informationLECTURE 10. PACKAGING TECHNOLOGY
LECTURE 10. PACKAGING TECHNOLOGY The increasing demand for fresh and quality packaged food, consumer convenience and manufacturers concern for longer shelf life of the food products is driving the market
More informationSummary Public Assessment Report. Generics. Triflu Paracetamol, Ascorbic acid, Pheniramine maleate MT/H/0172/001/DC
CMDh/305/2013 July 2014, Rev.01 Summary Public Assessment Report Generics Triflu Paracetamol, Ascorbic acid, Pheniramine maleate MT/H/0172/001/DC Date: 17 th August, 2016 Summary PAR Generics 1/3 Summary
More informationTopics covered by the talk
04/02/2016 Finished product monographs containing chemically defined active substances Dr Dirk Leutner Scientific Officer, European Pharmacopoeia Department European Directorate for the Quality of Medicines
More informationFAO SPECIFICATIONS FOR PLANT PROTECTION PRODUCTS (MERCURIAL SEED TREATMENTS) ETHOXYETHLYMERCURY CHLORIDE
AGP : CP / 86 FAO SPECIFICATIONS FOR PLANT PROTECTION PRODUCTS (MERCURIAL SEED TREATMENTS) ETHOXYETHLYMERCURY CHLORIDE FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS Rome, 1971 1 TABLE OF CONTENTS
More informationגדות תעשיות ביוכימיה בע"מ Gadot Biochemical Industries Ltd.
Description: Citric Acid is a widely used and environment-friendly acidulant. The acid is manufactured by a submerged fermentation process, using various natural carbohydrates as substrates. General Characteristics:
More informationPublic Assessment Report Scientific discussion. Echinaforce Forte, tablet. Asp. No:
Public Assessment Report Scientific discussion Echinaforce Forte, tablet Echinacea purpurea (L.) Moench (purple coneflower) herba recens, dry extract (17-34:1) and Echinacea purpurea (L.) Moench (purple
More informationDispersible aspirin tablets repacked into dosette boxes: Caution in practice
Dispersible aspirin tablets repacked into dosette boxes: Caution in practice Author Mylrea, Martina, Robertson, Sherryl, Haywood, Alison, Glass, Beverley Published 2013 Journal Title Australian Journal
More informationגדות תעשיות ביוכימיה בע"מ Gadot Biochemical Industries Ltd.
Description: A highly bioavailable source of Magnesium for food fortification. General Characteristics: Formula: modification on Mg 3 )C 6 H 5 O 7 ( 2.9H 2 O Appearance: White crystalline powder Odor:
More information2. Selection criteria for substances of herbal origin relevant for standardization and quality control of herbal medicines 77
Annex 1 WHO guidelines for selecting marker substances of herbal origin for quality control of herbal medicines 1. Introduction 72 1.1 Background 72 1.1.1 Preparation of the document 73 1.2 Objectives
More informationNatural Herbal Extracts Tongkat Ali (Eurycoma Longifolia)
Tongkat Ali (Eurycoma Longifolia) Male Menopause (Andropause): The reduction of male sex hormones When age increasing, the male s hormones i.e. Testosterone and Dehydroepiandrosterone will gradually decreasing
More informationCBD CAPSULE (5MG) DESCRIPTION HempFlax s CBD capsule is made of a decarboxylated supercritical CO 2 GENERAL INFORMATION
DESCRIPTION HempFlax s CBD capsule is made of a decarboxylated supercritical CO 2 extract of industrial hemp leaves from varieties registered on the EU list, mixed with cold pressed organic hemp seed oil.
More informationPhysicochemical analysis of Eraippu Noi Chooranam, A Siddha polyherbal formulation
International Journal of Advanced Multidisciplinary Research (IJAMR) ISSN: 2393-8870 www.ijarm.com Volume 3, Issue 6-2016 Research Article SOI: http://s-o-i.org/1.15/ijarm-2016-3-6-6 Physicochemical analysis
More informationThis PDF is available for free download
Research Paper www.ijpsonline.com Stability Studies on a Cough Syrup in Plastic Containers RENUKA GUPTA AND KAMALINDER K. SINGH* C. U. Shah College of Pharmacy, S. N. D. T. Women s University, Santacruz
More informationPublic Assessment Report. Scientific discussion. Rizatriptan Apotex disper 5 mg and 10 mg, orodispersible tablets. (rizatriptan benzoate)
Public Assessment Report Scientific discussion Rizatriptan Apotex disper 5 mg and 10 mg, orodispersible tablets (rizatriptan benzoate) NL/H/3152/001-002/DC Date: 4 July 2016 This module reflects the scientific
More informationProduct Data Sheet Hemp Oil 3% CBD. 1. General information. Best before: 06 / Product information: Appearance Ingredients CBD oil
1. General information 1.1 Product information: Appearance Ingredients CBD oil : CBD Oil in Glass bottle 10ml with dropper : Hemp extract and organic olive oil 1.2 Ingredients CBD Oil : Hemp extract :
More informationGuideline on quality of herbal medicinal products 2 /traditional herbal medicinal products
1 2 3 4 5 05 June 2018 EMA/HMPC/201116/2005 1 Rev. 3 Committee on Herbal Medicinal Products (HMPC) Guideline on quality of herbal medicinal products 2 /traditional herbal medicinal products DRAFT Revision
More informationDraft of Sanitation Standards for General Foods
Draft of Sanitation Standards for General Foods 17 and the second paragraph of 5 of the Act Governing Food Safety and Sanitation (herein referred to as "this Act"). For foods which have their own sanitation
More informationKNOWLEDGE OF SHELF LIFE OF DRUGS ( AYURVEDIC ) PRESENTED BY
KNOWLEDGE OF SHELF LIFE OF DRUGS ( AYURVEDIC ) PRESENTED BY Introduction Ayurveda is a natural gift to humanity for its betterment. Since ancient time human have feeling himself as a part of the Mother
More informationSUMMARY, CONCLUSION & RECOMMENDATIONS
196 Chapter-5 SUMMARY, CONCLUSION & RECOMMENDATIONS 197 CHAPTER 5 5.1 Summary, Conclusion and Recommendations Summary and Conclusion are drawn based on the work carried out by the author on development
More informationCommodity Code: Data Sheet Version: 1.6 Valid from (production date):
Product Description Ready-to-use neutral glaze for making mirrors on bavarois. Usage Information Usage rate / recipe Ready to use product. Do not add water. Application / Method Stir gently with a spatula
More informationGuideline on quality of herbal medicinal products 1 /traditional herbal medicinal products
31 March 2011 Committee for Medicinal Products for Human Use (CHMP) Committee for Medicinal Products for Veterinary Use (CVMP) Committee on Herbal Medicinal Products (HMPC) Guideline on quality of herbal
More informationStability Testing of Herbal Medicinal Products
Biopharma By Sven Oliver Kruse and Karim Sultan at Diapharm Stability Testing of Herbal Medicinal Products Particular legal requirements for quality control and stability studies of herbal medicinal products
More informationPublic Assessment Report Scientific discussion
Public Assessment Report Scientific discussion Galexir, oral solution (Cynara scolymus (artichoke) dried leaf / Gentiana lutea (gentian) dried root /Curcuma longa (turmeric) dried rhizome, liquid extract,
More informationTEST REPORT APPLICANT : CSP INC ADDRESS : 8248 W. ORANGE DR GLENDALE, AZ USA SAMPLE DESCRIPTION : HAND SANITIZER BUDDY WITH HAND SANITIZER
PAGE: 1 of 6 TEST REPORT APPLICANT : CSP INC ADDRESS : 8248 W. ORANGE DR GLENDALE, AZ 85303 USA SAMPLE DESCRIPTION : HAND SANITIZER BUDDY WITH HAND SANITIZER STYLE / ITEM NO. : K5-506 BUYER : KIDS' KORNER
More informationTechnical Specifications for the manufacture of: CANNED BEEF
Technical Specifications for the manufacture of: CANNED BEEF Specification reference: Canned Beef Version: 1.0 Date of issue: 30 th March 2010 1. SCOPE This specification applies to Canned Beef distributed
More informationASSAY AND IMPURITY METHOD FOR DURACOR TABLETS BY HPLC
ASSAY AND IMPURITY METHOD FOR DURACOR TABLETS BY HPLC METHOD APPROVALS Norvin Pharma Inc. Author Analytical Laboratory Approver Analytical Laboratory Group Leader Approver Manager Quality Control Chemistry
More informationTANZANIA BUREAU OF STANDARDS
Draft Tanzania Standard Ready to eat food for special people with Malnutrition - Specification TANZANIA BUREAU OF STANDARDS 1 Ready to eat food for people with Malnutrition Specification (Draft for comments
More informationTarget Group Multiple micronutrient powder is used for children 6 59 months of age. Primary target: 6-24 months of age.
General Description, single-use 1 gram sachets, packs of 30 sachets. MNPs are designed for point of use fortification of complementary foods for children and vulnerable populations to address anaemia and
More information